Johnson & Johnson
JNJ
$167.33
$2.591.57%
NYSE
06/29/2025 | 03/30/2025 | 12/29/2024 | 09/29/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 5.77% | 2.39% | 5.26% | 5.25% | 4.31% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 5.77% | 2.39% | 5.26% | 5.25% | 4.31% |
Cost of Revenue | 10.86% | 11.45% | 6.03% | 5.91% | 6.27% |
Gross Profit | 3.53% | -1.58% | 4.92% | 4.96% | 3.47% |
SG&A Expenses | 5.62% | -0.92% | 11.90% | 2.14% | 8.14% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 7.84% | 2.53% | 11.31% | 13.31% | 3.34% |
Operating Income | 0.95% | 2.03% | -15.47% | -13.67% | 6.65% |
Income Before Tax | 12.93% | 267.02% | -19.46% | -36.02% | -8.85% |
Income Tax Expenses | -10.17% | 473.42% | -34.29% | -29.07% | 14.19% |
Earnings from Continuing Operations | 18.16% | 237.91% | -16.97% | -37.48% | -12.83% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 18.16% | 237.91% | -15.26% | -89.65% | -8.90% |
EBIT | 0.95% | 2.03% | -15.47% | -13.67% | 6.65% |
EBITDA | 2.64% | 1.05% | -4.96% | -10.41% | 3.25% |
EPS Basic | 18.18% | 238.06% | -3.41% | -89.15% | -1.65% |
Normalized Basic EPS | -3.67% | 3.99% | -13.89% | -4.91% | 18.25% |
EPS Diluted | 18.65% | 238.81% | -3.38% | -89.13% | -1.61% |
Normalized Diluted EPS | -3.58% | 4.22% | -13.89% | -4.73% | 18.74% |
Average Basic Shares Outstanding | -0.02% | -0.04% | -12.27% | -4.59% | -7.37% |
Average Diluted Shares Outstanding | -0.12% | -0.26% | -12.27% | -4.78% | -7.76% |
Dividend Per Share | 4.84% | 4.20% | 4.20% | 4.20% | 4.20% |
Payout Ratio | -0.11% | -0.69% | 0.23% | -- | 0.06% |